JAGUAR HEALTH INC (JAGX:NASDAQ)

$0.9194 -0.0055 (-0.5947%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 80

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed JAGUAR HEALTH INC (JAGX:NASDAQ) News Sources

Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, Announces Positive Results of Preclinical Study of Coca for Weight Gain Prevention

18-06-2026

yahoo.com

Jaguar Health Announces Plan to Explore Strategic Alternatives Aligned with Targeted NDA Filing for Rare Disease Intestinal Failure Program

22-06-2026

yahoo.com

Jaguar Health Completes Submission of New Animal Drug Application for Full FDA Approval of Crofelemer for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs

23-06-2026

yahoo.com

Jaguar Health Announces Conversion of Series O Convertible Preferred Stock Issued as Recent One-time Stock Dividend

25-06-2026

yahoo.com

Presentation at ESPGHAN 2026 Describes Additional Groundbreaking Results of Evaluation of Jaguar Health's Crofelemer as Adjunctive Oral Therapy for the Treatment of Pediatric Intestinal Failure (IF)

30-06-2026

yahoo.com

Jaguar Health Reports Positive Consumer and Veterinary Market Research Findings Supporting Commercial Opportunity for Neonorm Dog

28-07-2026

yahoo.com

Jaguar Health Satisfies Conditions for Receipt of Non-Dilutive $2 Million Holdback Payment from Future Pak for Commercial License to Mytesi and Canalevia-CA1

05-08-2026

yahoo.com

Jaguar Health Reports Second Quarter 2026 Financials

19-08-2026

yahoo.com

Jaguar Health Inc (JAGX) (Q2 2026) Earnings Call Highlights: Rare Disease Breakthroughs and ...

20-08-2026

yahoo.com

Commercial Launch Initiated for Neonorm Dog, Jaguar Health's Non-Prescription Product for Support of Normal Stool Consistency and GI Fluid Balance in Dogs

26-08-2026

yahoo.com

JAGUAR HEALTH INC (JAGX:NASDAQ) Sentiment Trend

0 25 50 75 100 57 66 74 82 82 86 82 89 91 91 18-06-2026 22-06-2026 23-06-2026 25-06-2026 30-06-2026 28-07-2026 05-08-2026 19-08-2026 20-08-2026 26-08-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

JAGUAR HEALTH INC (JAGX:NASDAQ) FAQs

toggle

What is the current price of JAGUAR HEALTH INC (JAGX:NASDAQ)?

The current price of JAGUAR HEALTH INC (JAGX:NASDAQ) is $0.9194.


toggle

JAGUAR HEALTH INC (JAGX:NASDAQ) absolute price change since previous trading day?

The absolute price change of JAGUAR HEALTH INC (JAGX:NASDAQ) since the previous trading day is $-0.0055.


toggle

JAGUAR HEALTH INC (JAGX:NASDAQ) percentage price change since previous trading day?

The percentage price change of JAGUAR HEALTH INC (JAGX:NASDAQ) since the previous trading day is -0.5947%.


toggle

What is the most recent average sentiment score for JAGUAR HEALTH INC (JAGX:NASDAQ)?

The most recent average sentiment score for JAGUAR HEALTH INC (JAGX:NASDAQ) is 80 out of 100.


toggle

What is the most recent average sentiment for JAGUAR HEALTH INC (JAGX:NASDAQ)?

The most recent sentiment for JAGUAR HEALTH INC (JAGX:NASDAQ) is .


SEC-8K** Filing Available For JAGUAR HEALTH INC (JAGX:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.